share_log

Waters Co. (NYSE:WAT) Shares Acquired by Bank of America Corp DE

Waters Co. (NYSE:WAT) Shares Acquired by Bank of America Corp DE

沃特斯公司(纽约证券交易所代码:WAT)被美国银行收购的股票
Defense World ·  2022/09/24 05:51

Bank of America Corp DE lifted its holdings in shares of Waters Co. (NYSE:WAT – Get Rating) by 2.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 347,839 shares of the medical instruments supplier's stock after acquiring an additional 7,729 shares during the quarter. Bank of America Corp DE owned about 0.58% of Waters worth $107,964,000 as of its most recent filing with the Securities and Exchange Commission.

美国银行(Bank Of America Corp DE)最近向美国证券交易委员会(Securities And Exchange Commission)提交的13F文件显示,该公司在第一季度增持了Waters Co.(纽约证券交易所代码:WAT-GET)的股票2.3%。该机构投资者在本季度额外收购了7729股后,持有这家医疗器械供应商的347,839股股票。截至最近提交给美国证券交易委员会(Securities And Exchange Commission)的文件,美国银行DE持有Waters约0.58%的股份,价值107,964,000美元。

Several other hedge funds and other institutional investors have also made changes to their positions in the business. MainStreet Investment Advisors LLC lifted its holdings in shares of Waters by 0.7% during the 1st quarter. MainStreet Investment Advisors LLC now owns 4,757 shares of the medical instruments supplier's stock valued at $1,476,000 after acquiring an additional 35 shares in the last quarter. Camden Capital LLC lifted its holdings in Waters by 3.3% in the 4th quarter. Camden Capital LLC now owns 1,122 shares of the medical instruments supplier's stock worth $418,000 after buying an additional 36 shares in the last quarter. FDx Advisors Inc. lifted its holdings in Waters by 5.0% in the 1st quarter. FDx Advisors Inc. now owns 776 shares of the medical instruments supplier's stock worth $241,000 after buying an additional 37 shares in the last quarter. Signaturefd LLC lifted its holdings in Waters by 6.1% in the 1st quarter. Signaturefd LLC now owns 660 shares of the medical instruments supplier's stock worth $205,000 after buying an additional 38 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV lifted its holdings in Waters by 0.9% in the 1st quarter. Massmutual Trust Co. FSB ADV now owns 4,556 shares of the medical instruments supplier's stock worth $1,414,000 after buying an additional 40 shares in the last quarter. Institutional investors and hedge funds own 88.80% of the company's stock.

其他几家对冲基金和其他机构投资者也改变了他们在该业务中的头寸。MainStreet Investment Advisors LLC在第一季度增持了0.7%的Waters股票。MainStreet Investment Advisors LLC现在拥有这家医疗器械供应商4,757股股票,价值1,476,000美元,上个季度又收购了35股。Camden Capital LLC在第四季度增持了3.3%的Waters股份。Camden Capital LLC现在拥有这家医疗器械供应商1,122股股票,价值418,000美元,上个季度又购买了36股。第一季度,FDX Advisors Inc.增持Waters股票5.0%。FDX Advisors Inc.现在持有这家医疗器械供应商776股股票,价值241,000美元,此前该公司在上个季度又购买了37股。Signaturefd LLC在第一季度增持了6.1%的Waters股份。Signaturefd LLC现在持有这家医疗器械供应商660股股票,价值20.5万美元,上个季度又购买了38股。最后,MassMutual Trust Co.FSB ADV在第一季度增持了0.9%的Waters股份。MassMutual Trust Co.FSB ADV目前持有这家医疗器械供应商4,556股股票,价值1,414,000美元,此前该公司在上个季度又购买了40股。机构投资者和对冲基金持有该公司88.80%的股票。

Get
到达
Waters
水域
alerts:
警报:

Waters Price Performance

水域价格表现

Shares of NYSE:WAT opened at $275.50 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.10 and a debt-to-equity ratio of 3.66. Waters Co. has a fifty-two week low of $270.36 and a fifty-two week high of $399.81. The firm has a 50-day simple moving average of $319.36 and a 200 day simple moving average of $320.70. The company has a market cap of $16.50 billion, a PE ratio of 24.04, a P/E/G ratio of 3.05 and a beta of 0.87.

周五,纽约证交所:WAT的股价开盘报275.50美元。该公司的速动比率为1.55,流动比率为2.10,债务权益比为3.66。Waters Co.的股价为270.36美元,为52周低点,52周高点为399.81美元。该公司的50日简单移动均线切入位在319.36美元,200日简单移动均线切入位在320.70美元。该公司市值165亿美元,市盈率24.04倍,市盈率3.05倍,贝塔系数0.87。

Waters (NYSE:WAT – Get Rating) last announced its quarterly earnings data on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.12. Waters had a net margin of 24.21% and a return on equity of 203.31%. The business had revenue of $714.30 million during the quarter, compared to the consensus estimate of $706.77 million. During the same quarter in the prior year, the firm earned $2.60 EPS. The company's revenue for the quarter was up 4.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Waters Co. will post 12 EPS for the current year.
Waters(纽约证券交易所代码:WAT-GET评级)上一次公布季度收益数据是在8月2日星期二。这家医疗器械供应商公布本季度每股收益为2.75美元,比分析师普遍预期的2.63美元高出0.12美元。Waters的净利润率为24.21%,股本回报率为203.31%。该业务本季度的收入为7.143亿美元,而普遍预期为7.0677亿美元。去年同期,该公司每股收益为2.60美元。与去年同期相比,该公司本季度的收入增长了4.8%。卖方分析师平均预计Waters Co.本年度每股收益将达到12欧元。

Analyst Ratings Changes

分析师评级发生变化

A number of equities analysts have commented on WAT shares. Credit Suisse Group started coverage on shares of Waters in a report on Wednesday, August 24th. They issued a "neutral" rating and a $345.00 price objective on the stock. UBS Group boosted their price objective on shares of Waters from $349.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, August 4th. Barclays dropped their target price on shares of Waters from $375.00 to $345.00 and set an "overweight" rating for the company in a research report on Monday, September 12th. Cowen boosted their target price on shares of Waters to $378.00 in a research report on Tuesday, August 9th. Finally, Robert W. Baird boosted their target price on shares of Waters from $340.00 to $348.00 in a research report on Wednesday, August 3rd. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $348.25.

许多股票分析师对Wat股票发表了评论。瑞士信贷集团在8月24日星期三的一份报告中开始报道Waters的股票。他们对该股给予了“中性”评级和345.00美元的目标价。瑞银集团将Waters股票的目标价从349.00美元上调至375.00美元,并在8月4日周四的一份报告中给予该股“中性”评级。巴克莱将Waters股票的目标价从375.00美元下调至345.00美元,并在9月12日周一的一份研究报告中对该公司设定了“增持”评级。考恩在8月9日周二的一份研究报告中将Waters的目标股价上调至378.00美元。最后,罗伯特·W·贝尔德在8月3日星期三的一份研究报告中将Waters的目标股价从340.00美元上调至348.00美元。五名投资分析师对该股的评级为持有,两名分析师对该公司股票的评级为买入。根据MarketBeat的数据,该公司的平均评级为“持有”,平均目标价为348.25美元。

Waters Profile

水域纵断面

(Get Rating)

(获取评级)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Waters Corporation是一家专业测量公司,在亚洲、美洲和欧洲提供分析工作流程解决方案。它通过两个部门运营,Waters和TA。该公司设计、制造、销售和服务高性能和超高性能液相色谱,以及质谱仪(MS)技术系统和支持产品,包括色谱柱、其他消耗品和保修后服务计划。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on Waters (WAT)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • 2 Semiconductor Stocks To Watch For Reversals
  • 免费获取StockNews.com关于Waters的研究报告(Wat)
  • MarketBeat:回顾一周9/19-9/23
  • 为什么特斯拉的股票保持弹性?
  • CrowdStrike是否会从增加每股收益指引中获得提振?
  • 好市多盈利后价格疲软是买入的好时机吗?
  • 需要关注的2只半导体类股走势逆转

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Waters Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Waters和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发